MedPath

Levetiracetam Treatment of Children With Subclinical Sleep-Activated Epileptiform Activity (SSEA)

Phase 4
Conditions
Subclinical Sleep-Activated Epileptiform Activity
CSWS
Registration Number
NCT00393614
Lead Sponsor
Oslo University Hospital
Brief Summary

In clinical practice at the National centre for epilepsy (SSE) in Norway we see many children who have subclinical epileptiform activity in EEG that increases substantially during slow wave sleep (SSEA; subclinical sleep-activated epileptiform activity). They may or may not have seizures. Hence, according to the definition some children with SSEA do not suffer from epilepsy because they do not experience seizures. Many of these children have symptoms such as: attention deficit hyperactivity disorders (AD/HD), dyslectic problems, sleep problems, tantrums or autistic symptoms . We hypothesize that this subclinical epileptiform activity during slow sleep may act negatively on cognitive functions, language and behaviour in some children; even when the spike-wave discharges are less frequent than in CSWS (continuous spike-waves during slow sleep).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Children 5-10 years
  • IQ > 50
Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
24 hour EEGEnd of the study
Secondary Outcome Measures
NameTimeMethod
Health related quality of lifeEnd of the study
Neuro-psychological testing,End of the study
Behavioral problemsEnd of the study

Trial Locations

Locations (1)

Rikshospitalet-Radiumhospitalet HF

🇳🇴

Oslo, Norway

© Copyright 2025. All Rights Reserved by MedPath